Thyrotrophin-releasing hormone receptor 1 and prothyrotrophin-releasing hormone mRNA expression in the central nervous system are regulated by suckling in lactating rats

European Journal of Endocrinology

Volumn 152, Issue 5, 2005, Pages 791-803

  Fjeldheim, Åse Karine ^a   Høvring, Per Ivar ^a   Løseth, Ole Petter ^a   Johansen, Per Wiik ^b   Glover, Joel C ^a   Matre, Vilborg ^a   Olstad, Ole Kristoffer ^c   Reppe, Sjur ^a   Ordeladze, Jan O ^a   Walaas, S Ivar ^a   Gautvik, Kaare M ^a,c  

^a UNIVERSITY OF OSLO   (Norway)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

^c ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

BROMOCRIPTINE; MESSENGER RNA; PROLACTIN; PROTIRELIN; PROTIRELIN RECEPTOR;

AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HORMONE BLOOD LEVEL; HORMONE RELEASE; HYPOTHALAMUS; IN SITU HYBRIDIZATION; LACTATION; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; QUANTITATIVE ANALYSIS; RAT; REAL TIME POLYMERASE CHAIN REACTION; RECEPTOR UPREGULATION; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; SUCKLING;

EID: 19944386991     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.1.01902     Document Type: Article

References (66)

1. 2 administration in postpartum women. Journal of Clinical Endocrinology and Metabolism 1973 37 135-139.
2. Gautvik KM, Tashjian AH Jr, Kourides IA, Weintraub BD, Graeber CT, Maloof F, Suzuki K & Zuckerman JE. Thyrotropin-releasing hormone is not the sole physiologic mediator of prolactin release during suckling. New England Journal of Medicine 1974 290 1162-1165.
3. Grosvenor CE, Mena F & Whitworth NS. Evidence that the dopaminergic prolactin-inhibiting factor mechanism regulates only the depletion-transformation phase and not the release phase of prolactin secretion during suckling in the rat. Endocrinology 1980 106 481-485.
4. de Greef WJ, Klootwijk W, Karels B & Visser TJ. Levels of dopamine and thyrotropin-releasing hormone in hypophysial stalk blood during an oestrogen-stimulated surge of prolactin in the ovariectomized rat. Journal of Endocrinology 1985 105 107-112.
5. Mori M & Yamada M. Thyroid hormones regulate the amount of thyrotropin-releasing hormone in the hypothalamic median eminence of the rat. Journal of Endocrinology 1987 114 443-448.
6. Haisenleder DJ, Ortolano GA, Dalkin AC, Yasin M & Marshall JC. Differential actions of thyrotropin (TSH)-releasing hormone pulses in the expression of prolactin and TSH subunit messenger ribonucleic acid in rat pituitary cells in vitro. Endocrinology 1992 130 2917-2923.
7. Aizawa T & Greer MA. Delineation of the hypothalamic area controlling thyrotropin secretion in the rat. Endocrinology 1981 109 1731-1738.
8. de Greef WJ & Visser TJ. Evidence for the involvement of hypothalamic dopamine and thyrotropin-releasing hormone in suckling-induced release of prolactin. Journal of Endocrinology 1981 91 213-223.
9. de Greef WJ, Voogt JL, Visser TJ, Lamberts SW & van der Schoot P. Control of prolactin release induced by suckling. Endocrinology 1987 121 316-322.
10. Leblanc H, Lachelin GC, Abu-Fadil S & Yen SS. Effects of dopamine infusion on pituitary hormone secretion in humans. Journal of Clinical Endocrinology and Metabolism 1976 43 668-674.
11. Scanlon MF, Weightman DR, Shale DJ, Mora B, Heath M, Snow MH, Lewis M & Hall R. Dopamine is a physiological regulator of thyrotropin (TSH) secretion in normal man. Clinical Endocrinology 1979 10 7-15.
12. Blake CA. Stimulation of pituitary prolactin and TSH release in lactating and proestrous rats. Endocrinology 1974 94 503-508.
13. Riskind PN, Millard WJ & Martin JB. Evidence that thyrotropin-releasing hormone is not a major prolactin-releasing factor during suckling in the rat. Endocrinology 1984 115 312-316.
14. Sheward WJ, Fraser HM & Fink G. Effect of immunoneutralization of thyrotropin-releasing hormone on the release of thyrotropin and prolactin during suckling or in response to electrical stimulation of the hypothalamus in the anaesthetized rat. Journal of Endocrinology 1985 106 113-119.
15. Uribe RM, Redondo JL, Charli JL & Joseph-Bravo P. Suckling and cold stress rapidly and transiently increase TRH mRNA in the paraventricular nucleus. Neuroendocrinology 1993 58 140-145.
16. Walaas SI, Nairn AC & Greengard P. Regional distribution of calcium- and cyclic adenosine 3′,5′-monophosphate-regulated protein phosphorylation systems in mammalian brain. I. Particulate systems. Journal of Neuroscience 1983 3 291-301.
17. Paxinos G, Watson C. The Rat Brain in Stereotaxic Coordinates. San Diego: Academic Press Inc., 1998.
18. Haug E & Gautvik KM. Radioimmunoassay of rat prolactin and its use in measuring prolactin production by cultured pituitary cells. Acta Endocrinologica 1976 82 282-297.
19. Chirgwin JM, Przybyla AE, MacDonald RJ & Rutter WJ. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 1979 18 5294-5299.
20. Sambrook J, Fritsch EF & Maniatis T. Molecular Cloning, A Laboratory Manual. New York: Cold Spring Harbor Laboratory Press, 1989.
21. Matre V, Karlsen HE, Wright MS, Lundell I, Fjeldheim Å-K, Gabrielsen OS, Larhammar D & Gautvik KM. Molecular cloning of a functional human thyrotropin-releasing hormone receptor. Biochemical and Biophysical Research Communications 1993 195 179-185.
22. Cao J, O'Donell D, Vu H, Payza K, Pou C, Godbout C, Jakob A, Pelletier M, Lembo P, Ahmad S & Walker P. Cloning and characterization of a cDNA encoding a novel subtype of rat thyrotropin-releasing hormone receptor. Journal of Biological Chemistry 1998 273 32281-32287.
23. Itadani H, Nakamura T, Itoh J, Iwaasa H, Kanatani A, Borkowski J, Ihara M & Ohta M. Cloning and characterization of a new subtype of thyrotropin-releasing hormone receptors. Biochemical and Biophysical Research Communications 1998 250 68-71.
24. Ovstebo R, Foss Haug KB, Lande K & Kierulf P. PCR-based calibration curves for studies of quantitative gene expression in human monocytes: development and evaluation. Clinical Chemistry 2003 49 425-432.
25. Hoover F & Goldman D. Temporally correlated expression of nAChR genes during development of the mammalian retina. Experimental Eye Research 1992 54 561-571.
26. Torp R, Hoover F, Danbolt NC, Storm-Mathisen J & Ottersen OP. Differential distribution of the glutamate transporters GLT1 and rEAAC1 in rat cerebral cortex and thalamus: an in situ hybridization analysis. Anatomy and Embryology 1997 195 317-326.
27. Clark BJ, Fluckiger E, Lowe DM & Vigouret JM. How does bromocriptine work? Triangle 1978 1 21-32.
28. Nillni EA, Aird F, Seidah NG, Todd RB & Koenig JI. Pre-proTRH(178-199) and two novel peptides (pFQ7 and pSE14) derived from its processing, which are produced in the paraventricular nucleus of the rat hypothalamus, are regulated during suckling. Endocrinology 2001 142 896-906.
29. Mangurian LP, Walsh RJ & Posner BI. Prolactin enhancement of its own uptake at the choroid plexus. Endocrinology 1992 131 698-702.
30. Mezey E & Palkovits M. Two-way transport in the hypothalamohypophyseal system. In Frontiers in Neuroendocrinology, pp 1-29. Eds WF Ganong & L Martini. New York: Raven Press, 1982.
31. Oliver C, Mical RS & Porter JC. Hypothalamic-pituitary vasculature: evidence for retrograde blood flow in the pituitary stalk. Endocrinology 1977 101 598-604.
32. Chiu S, Koos RD & Wise PM. Detection of prolactin receptor (PRL-R) mRNA in the rat hypothalamus and pituitary gland. Endocrinology 1992 130 1747-1749.
33. Grattan DR. The actions of prolactin in the brain during pregnancy and lactation. Progress in Brain Research 2001 133 153-171.
34. Martinez de la Escalera G & Weiner RI. Dissociation of dopamine from its receptor as a signal in the pleiotropic hypothalamic regulation of prolactin secretion. Endocrine Reviews 1992 13 241-255.
35. Torner L, Maloumby R, Nava G, Aranda J, Clapp C & Neumann ID. In vivo release and gene upregulation of brain prolactin in response to physiological stimuli. European Journal of Neuroscience 2004 19 1601-1608.
36. Pi X-J & Grattan DR. Differential expression of the two forms of prolactin receptor mRNA within microdissected hypothalamic nuclei of the rat. Molecular Brain Research 1998 59 1-12.
37. Freeman ME, Kanyicska B, Lerant A & Nagy G. Prolactin: structure, function, and regulation of secretion. Physiological Reviews 2000 80 1523-1631.
38. Horseman ND & Yu-Lee LY. Transcriptional regulation by the helix bundle peptide hormones: growth hormone, prolactin, and hematopoietic cytokines. Endocrine Reviews 1994 15 627-649.
39. Matre V, Hovring PI, Orstavik S, Frengen E, Rian E, Velickovic Z, Murray-McIntosh RP & Gautvik KM. Structural and functional organization of the gene encoding the human thyrotropin-releasing hormone receptor. Journal of Neurochemistry 1999 72 40-50.
40. Hovring PI, Matre V, Fjeldheim AK, Loseth OP & Gautvik KM. Transcription of the human thyrotropin-releasing hormone receptor gene - analysis of basal promoter elements and glucocorticoid response elements. Biochemical and Biophysical Research Communications 1999 257 829-834.
41. Stoecklin E, Wissler M, Gouilleux F & Groner B. Functional interactions between Stat5 and the glucocorticoid receptor. Nature 1996 383 726-728.
42. Stoecklin E, Wissler M, Moriggl R & Groner B. Specific DNA binding of Stat5, but not of glucocorticoid receptor, is required for their functional cooperation in the regulation of gene transcription. Molecular and Cellular Biology 1997 17 6708-6716.
43. Johansen PW, Paulssen RH, Bioro T, Gautvik KM & Gordeladze JO. Distinct guanine nucleotide binding protein alpha-subunit receptor coupling in GH cell lines: effects of bromocriptine and hormones on effector enzyme modulation. Cellular Physiology and Biochemistry 2001 11 339-352.
44. Renodon A, Boucher JL, Sari MA, Delaforge M, Ouazzani J & Mansuy D. Bromocriptine is a strong inhibitor of brain nitric oxide synthase: possible consequences for the origin of its therapeutic effects. FEBS Letters 1997 406 33-36.
45. Camanni F, Massara F, Fassio V, Molinatti GM & Muller EE. Effect of five dopaminergic drugs on plasma growth hormone levels in acromegalic subjects. Neuroendocrinology 1975 19 227-240.
46. Cooke I, Foley M, Lenton E, Preston E, Millar D, Jenkins A, Obiekwe B, McNeilly A, Parsons J & Kennedy G. The treatment of puerperal lactation with bromocriptine. Postgraduate Medical Journal 1976 52 (Suppl 1) 75-80.
47. Prysor-Jones RA & Jenkins JS. Effect of bromocriptine, ergotamine and other ergot alkaloids on the hormone secretion and growth of a rat pituitary tumour. Journal of Endocrinology 1980 86 147-153.
48. 2+ fluxes in cultured rat pituitary adenoma cells. Acta Endocrinologica 1986 111 185-192.
49. Halse J, Harris AG, Kvistborg A, Kjartansson O, Hanssen E, Smiseth O, Djosland O, Hass G & Jervell J. A randomized study of SMS 201-995 versus bromocriptine treatment in acromegaly: clinical and biochemical effects. Journal of Clinical Endocrinology and Metabolism 1990 70 1254-1261.
50. Jaffe CA & Barkan AL. Treatment of acromegaly with dopamine agonists. Endocrinology and Metabolism Clinics of North America 1992 21 713-735.
51. Aragay AM, Katz A & Simon MI. The G alpha q and G alpha 11 proteins couple the thyrotropin-releasing hormone receptor to phospholipase C in GH3 rat pituitary cells. Journal of Biological Chemistry 1992 267 24983-24988.
52. Hsieh KP & Martin TF. Thyrotropin-releasing hormone and gonadotropin-releasing hormone receptors activate phospholipase C by coupling to the guanosine triphosphate-binding proteins Gq and G11. Molecular Endocrinology 1992 6 1673-1681.
53. Gautvik KM, Gordeladze JO, Janhsen T, Haug E, Hansson V & Lystad E. Thyroliberin receptor binding and adenylyl cyclase activation in cultured prolactin-producing rat pituitary tumor cells (GH cells). Journal of Biological Chemistry 1983 258 10304-10311.
54. Paulssen RH, Paulssen EJ, Gautvik KM & Gordeladze JO. The thyroliberin receptor interacts directly with a stimulatory guanine-nucleotide-binding protein in the activation of adenylyl cyclase in GH3 rat pituitary tumour cells. Evidence obtained by the use of antisense RNA inhibition and immunoblocking of the stimulatory guanine-nucleotide-binding protein. European Journal of Biochemistry 1992 204 413-418.
55. Wettschureck N, Moers A, Hamalainen T, Lemberger T, Shcutz G & Offermanns S. Heterotrimeric G proteins of the Gq/11 family are crucial for the induction of maternal behaviour in mice. Molecular and Cellular Biology 2004 24 8048-8054.
56. Johansen PW, Clausen OP, Haug E, Fossum S & Gautvik KM. Effects of bromocriptine on cell cycle distribution and cell morphology in cultured rat pituitary adenoma cells. Acta Endocrinologica 1985 110 319-328.
57. Johansen PW, Haug E & Gautvik KM. Effects of bromocriptine on hormone production and cell growth in cultured rat pituitary cells. Acta Endocrinologica 1985 110 200-206.
58. Vargas MA, Bourdais J, Sanchez S, Uriostegui B, Moreno E, Joseph-Bravo P & Charli JL. Multiple hypothalamic factors regulate pyroglutamyl peptidase II in cultures of adenohypophyseal cells: role of the cAMP pathway. Journal of Neuroendocrinology 1998 10 199-206.
59. Cunningham ET Jr & Sawchenko PE. Reflex control of magnocellular vasopressin and oxytocin secretion. Trends in Neuroscience 1991 14 406-411.
60. Aguilera G, Lightman SL & Kiss A. Regulation of the hypothalamic-pituitary-adrenal axis during water deprivation. Endocrinology 1993 132 241-248.
61. Lim MM, Wang Z, Olazabal DE, Ren X, Terwilliger EF & Young LJ. Enhanced partner preference in a promiscuous species by manipulating the expression of a single gene. Nature 2004 429 754-757.
62. Ciosek J & Guzek JW. Thyrotropin-releasing hormone affects the oxytocin, vasopressin and prolactin release in female rats during midlactation: relation to suckling. Journal of Physiology and Pharmacology 1998 49 135-150.
63. Vacher CM, Frétier P. Crémion C, Calas A & Hardin-Pouzet H. Activation by serotonin and noradrenaline of vasopressin and oxytocin expression in the mouse paraventricular and supraoptic nuclei. Journal of Neuroscience 2002 22 1513-1522.
64. Brunetti L, Orlando G, Michelotto B, Recinella L & Vacca M. Cocaine- and amphetamine-regulated transcript peptide-(55-102) and thyrotropin releasing hormone inhibit hypothalamic dopamine release. European Journal of Pharmacology 2000 409 103-107.
65. Yamada M, Satoh T & Mori M. Mice lacking the thyrotropin-releasing hormone gene: what do they tell us? Thyroid 2003 13 1111-1121.
66. Sanchez E, Uribe RM, Corkidi G, Zoeller RT, Cisneros M, Zacarias M, Morales-Chapa C, Charli JL & Joseph-Bravo P. Differential responses of thyrotropin-releasing hormone (TRH) neurons to cold exposure or suckling indicate functional heterogeneity of the TRH system in the paraventricular nucleus of the rat hypothalamus. Neuroendocrinology 2001 74 407-422.